← Open Payments lookup

TRACY COE: Open Payments

NPI 1275568602 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,447 in 89 payments from 14 companies in 2025. Trend: 2023 $1,849 · 2024 $1,860 · 2025 $2,447

Food & beverage: $2,447
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$678
Regeneron Healthcare Solutions, Inc.20$407
GENZYME CORPORATION5$300
Takeda Pharmaceuticals U.S.A., Inc.10$187
GlaxoSmithKline, LLC.14$161
Blueprint Medicines Corporation2$159
Grifols USA, LLC7$142
Novartis Pharmaceuticals Corporation5$127
ARS Pharmaceuticals Operations, Inc.5$108
Optinose US, Inc.3$66

Products named: DUPIXENT, TEZSPIRE, CUVITRU, AYVAKIT, FASENRA, Xembify, Xolair, NEFFY.

Industry payments across TX — which companies pay providers there.